Metropolitan Jonathan refuses exchange to Russia

Metropolitan Jonathan (Yeletskikh). Photo: Press Service of the Tulchyn Eparchy

The convicted head of the Tulchyn Eparchy of the Ukrainian Orthodox Church, Metropolitan Jonathan (Yeletskikh), has refused to be included in the exchange fund as a prisoner of war for transfer to Russia, reports Glavcom citing court registry data.

The UOC hierarch’s lawyer stated that his client wrote an application for exchange while undergoing treatment at a cardiology center following a stroke. However, Metropolitan Jonathan does not have the status of a prisoner of war, does not admit his guilt, and "wants to continue working for the benefit of Ukraine".

During the session, Met. Jonathan stressed that he wrote the application himself, but now, since he does not have the status of a prisoner of war, he has changed his mind.

As reported by UOJ, the ruling bishop of the Tulchyn Eparchy was sentenced to 5 years of imprisonment with confiscation of property.

Read also

UOC Primate blesses special prayer rule for Great Lent

Metropolitan Onuphry blessed to pray for peace in Ukraine during Great Lent.

In Britain, Christians are no longer majority

According to a Pew Research Center study, the share of Christians in the United Kingdom has fallen below 50%.

His Beatitude Onuphry addresses flock before Great Lent

The Primate of the UOC blessed the faithful for the upcoming Great Lent.

Lavra Reserve complains to UNESCO about heating and power outage

International experts studied possible threats to the Kyiv-Pechersk Lavra – from missile strikes to power and heating outages.

Konotop Eparchy Administration is under repair after shelling

The replacement of the windows damaged as a result of the shelling in the Church of All Saints and the building of the Konotop Eparchy has become possible thanks to donations from believers.

Priests and laity of Rivne Eparchy donate blood for children with cancer

In Rivne, the UOC clergy and laity have donated blood for children undergoing treatment for cancer.